BR112016029013A2 - aperfeiçoamento em composição nasal e método de utilização do mesmo - Google Patents

aperfeiçoamento em composição nasal e método de utilização do mesmo

Info

Publication number
BR112016029013A2
BR112016029013A2 BR112016029013A BR112016029013A BR112016029013A2 BR 112016029013 A2 BR112016029013 A2 BR 112016029013A2 BR 112016029013 A BR112016029013 A BR 112016029013A BR 112016029013 A BR112016029013 A BR 112016029013A BR 112016029013 A2 BR112016029013 A2 BR 112016029013A2
Authority
BR
Brazil
Prior art keywords
composition
improvement
nasal composition
nasal
patient
Prior art date
Application number
BR112016029013A
Other languages
English (en)
Inventor
A Popov Todor
Original Assignee
Nasaleze Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nasaleze Patents Ltd filed Critical Nasaleze Patents Ltd
Publication of BR112016029013A2 publication Critical patent/BR112016029013A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

uma composição nasal é revelada, compreendendo ou consistindo em uma primeira parte da composição sob a forma de um líquido para aplicação nasal para uso em um paciente e uma segunda parte da composição sob a forma de um pó para aplicação nasal para uso no paciente. a primeira e segunda partes da composição são aplicadas no paciente separadamente ou em conjunto, conforme necessário.
BR112016029013A 2014-06-10 2015-06-08 aperfeiçoamento em composição nasal e método de utilização do mesmo BR112016029013A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1410250.3A GB201410250D0 (en) 2014-06-10 2014-06-10 Improvements to nasal compositions and method of use thereof
PCT/GB2015/051661 WO2015189579A1 (en) 2014-06-10 2015-06-08 Improvements to nasal compositions and method of use thereof

Publications (1)

Publication Number Publication Date
BR112016029013A2 true BR112016029013A2 (pt) 2017-08-22

Family

ID=51266948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016029013A BR112016029013A2 (pt) 2014-06-10 2015-06-08 aperfeiçoamento em composição nasal e método de utilização do mesmo

Country Status (9)

Country Link
US (2) US20170239220A1 (pt)
EP (1) EP3154515B1 (pt)
JP (1) JP6762931B2 (pt)
CN (1) CN106794137B (pt)
BR (1) BR112016029013A2 (pt)
ES (1) ES2869912T3 (pt)
GB (1) GB201410250D0 (pt)
PL (1) PL3154515T3 (pt)
WO (1) WO2015189579A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410250D0 (en) 2014-06-10 2014-07-23 Nasaleze Patents Ltd Improvements to nasal compositions and method of use thereof
CA2923767A1 (en) 2016-03-14 2017-09-14 Timothy R. St. Germain Method of using n-hydroxy-1,4-napthalenedione as a novel herbicide
CN106361688B (zh) * 2016-08-26 2019-12-06 朱高 鼻腔洗液及其制备方法和应用
CN106890197B (zh) * 2017-04-11 2018-07-31 成都益植生物科技有限公司 一种定植益生菌制剂及其应用和药物
CN107582573A (zh) * 2017-08-23 2018-01-16 江苏微康生物科技有限公司 一种益生菌滴剂及其制备方法
CN109966324A (zh) * 2017-12-27 2019-07-05 北京盈科瑞药物安全有效性研究有限公司 一种银杏叶提取物雾化吸入用溶液制剂及其制备方法
TR201900055A2 (tr) * 2019-01-03 2019-03-21 Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret Anonim Sirketi Burun spreyi̇ formülasyonu
CA3179307A1 (en) * 2020-05-18 2021-11-25 Kenneth E. Palmer Compositions and methods for prevention of coronavirus infection
GB2611803A (en) 2021-10-15 2023-04-19 Nasaleze Patents Ltd Compositions of high viscosity
CN117771183B (zh) * 2024-02-27 2024-05-03 深圳大佛药业股份有限公司 一种盐酸羟甲唑啉喷雾剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
CA2583794C (en) * 2004-10-11 2015-05-26 Nasaleze Ppm Limited Compositions for intranasal administration
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
CN101564396A (zh) * 2009-06-15 2009-10-28 阳国平 治疗变应性鼻炎的两腔型鼻喷雾剂
GB201410250D0 (en) 2014-06-10 2014-07-23 Nasaleze Patents Ltd Improvements to nasal compositions and method of use thereof

Also Published As

Publication number Publication date
US20200054609A1 (en) 2020-02-20
PL3154515T3 (pl) 2021-08-09
EP3154515A1 (en) 2017-04-19
JP6762931B2 (ja) 2020-09-30
US11583519B2 (en) 2023-02-21
ES2869912T3 (es) 2021-10-26
EP3154515B1 (en) 2021-04-28
RU2016151683A (ru) 2018-07-10
GB201410250D0 (en) 2014-07-23
WO2015189579A1 (en) 2015-12-17
JP2017527608A (ja) 2017-09-21
RU2016151683A3 (pt) 2019-01-24
WO2015189579A9 (en) 2017-02-23
US20170239220A1 (en) 2017-08-24
CN106794137A (zh) 2017-05-31
CN106794137B (zh) 2021-10-15

Similar Documents

Publication Publication Date Title
BR112016029013A2 (pt) aperfeiçoamento em composição nasal e método de utilização do mesmo
BR112016003229A2 (pt) Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
EP3313404A4 (en) THERAPEUTIC COMPOSITIONS, ASSOCIATIONS AND METHODS OF USE
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
BR112016022062A2 (pt) Combinação, composição farmacêutica, uso de uma combinação ou de uma composição farmacêutica, e, produto farmacêutico
IL259246A (en) Preparations containing pharmaceutical substances and methods of using them
FR3021533B1 (fr) Composition cosmetique de type gel
ES2969758T3 (es) Composiciones farmacéuticas para usar en la terapia de la blefaritis
HUE041924T2 (hu) Hialuronsav alapú kozmetikai kompozíció, eljárás annak elõállítására, és annak alkalmazása
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
EA201991447A1 (ru) Снижение вязкости фармацевтических составов
EP3144292A4 (en) 2,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof
BR112014024448A2 (pt) composição, e, métodos para reduzir a viscosidade de um gel de polissacarídeo e para tratamento de uma formação subterrânea
EP3303498A4 (en) PHOTO-CURABLE ADHESIVE COMPOSITION, PREPARATION THEREOF, AND USE THEREOF
BR112015031417A8 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
EP3193919A4 (en) Immunogenic/therapeutic glycoconjugate compositions and uses thereof
IL252397A0 (en) Pharmaceutical preparations, their preparation and uses
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EP3472260A4 (en) COMPOSITIONS AND METHODS FOR THE PRODUCTION AND USE OF ACIDIFICATING MATERIALS
EP3181553A4 (en) Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof
EP3285758A4 (en) Co-crystal composition and its pharmaceutical use
IL290114A (en) Pharmaceutical preparations, their preparation and uses
EP3368592A4 (en) COSMETIC COMPOSITION, COSMETICS AND EXTERNAL PREPARATION FOR THE SKIN
BR112017002852A2 (pt) compostos de azetidiniloxifenilpirrolidina
CO2017001601A2 (es) Derivados de 1-acetil-4-((pirazin-2-il) amino)-1,2,3,4-tetrahydroquinolina-6 carboxamida como inhibidores de bromodominio

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]